Atom Investors’s Evolent Health EVH Stock Holding History

Atom Investors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$489K	Sell	90,138 -212,268	-70%	-$814K	0.04%	570
2026 Q1	$689K	Buy	302,406 +33,206	+12%	+$105K	0.05%	423
2025 Q4	$1.08M	Buy	+269,200	New	+$1.5M	0.09%	285
2022 Q2	–	Sell	-9,158	Closed	-$296K	–	271
2022 Q1	$296K	Buy	+9,158	New	+$240K	0.14%	142

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Atom Investors's EVH Position: Q2 2026 in Review

Atom Investors reduced its Evolent Health (EVH) stake by 70% in Q2 2026, selling an estimated $814K and leaving 90,138 shares worth $489K. The position accounts for 0.04% of the portfolio, ranked #570.

Atom Investors first reported a position in EVH in Q1 2022 and has held it in 4 quarters since. The position peaked at $1.08M in Q4 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Atom Investors held 90,138 shares of Evolent Health worth $489K as of Q2 2026.
Atom Investors sold 212,268 Evolent Health shares in Q2 2026, an estimated $814K.
Evolent Health made up 0.04% of Atom Investors's portfolio in Q2 2026, its #570 holding.
Atom Investors first reported a position in Evolent Health in Q1 2022 and has held it in 4 quarters since.
Atom Investors's Evolent Health position peaked at $1.08M in Q4 2025.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.